Wed, Jul 30, 2014, 4:23 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Neostem, Inc. Message Board

  • kwood1764 kwood1764 Jul 14, 2013 4:01 PM Flag

    A step back for the global view (part 1)

    A couple things....
    One of the topics of our favorite anti-NBS poster with a screen name A-12 frequently comments on ~ which is not arguable is the leadership since 2006, has been pretty consistent. From a shareholders perspective – and I am assuming A-12 is, if you owned since 2006, you are down over 90% since the current CEO took over Neostem, that is not debatable. That said, with the CEO still in place today and if your screen name starts with an A and end with 12 and you are all over the map with your negative comments, it’s difficult to take some of the collection of comments with any real level of seriousness, because 5 word posts… are generally not worthy of deep reflection, perspective and refute. But the overall point is in nearly 8 years, you can't be satisfied with your ROI and by correlation the leadership group.

    Personally I enjoy the overall forward movement (don’t get caught up on the day-to-day) of the company and think like one other commenter mentioned earlier this month that the PCT manufacturing arm, could be the future of the organization if a couple of these products (owned by others as well) do well. PCT is setting itself up to be the premier spot for bio-tech manufacturing. The comment comparing it to Google, which might have been a bit strong, but the point was well taken.

    For those of us newer to NBS with buy ins at .35c and then picking up shares along the way and cost average in the .50’s, and perhaps with longer term investment strategies (these small slices of good news - i.e. vatican relationships, patent updates) will have to suffice for now, but our course and goal for NBS is different. While we all want success, with AMR-001 and it’s the potential with heart attack clients, it’s the PCT manufacturing and new agreements we are more encouraged by because that’s where the current revenue is… that’s the short-term future.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.22+0.12(+1.97%)4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.